Gilead Sciences
February 17, 2026 • Ekalavya Hansaj
The Tenofovir Transition: Allegations of Delayed Safety Innovation In the high-stakes theater of antiviral pharmacology, few case studies rival the controversy surrounding Tenofovir. This narrative…